Ratings by HSBC (Morten Herholdt)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/10/2026 | Amgen | AMGN | Downgrade | Hold (Buy) |
393.17 (439.26) |
11.72% | Details | |
| 3/10/2026 | Johnson & Johnson | JNJ | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2024 | Laboratory Corporation of America | LH | Upgrade | Buy (Hold) |
228.09 (328.95) |
44.22% | Details | |
| 4/24/2024 | Gilead Sciences | GILD | Upgrade | Hold (Reduce) |
67.03 (156.04) |
132.79% | Details | |
| 4/18/2024 | Johnson & Johnson | JNJ | Upgrade | Buy (Hold) |
144.77 (263.81) |
82.23% | Details | |
| 3/4/2024 | bluebird bio | BLUE | Maintain | Reduce (N/A) |
|
Details | ||
| 2/19/2024 | Zoetis Inc. | ZTS | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2024 | Amgen | AMGN | Maintain | Buy (N/A) |
|
Details | ||
| 12/11/2023 | bluebird bio | BLUE | Downgrade | Reduce (Buy) |
2.86 (4.97) |
73.78% | Details | |
| 9/6/2023 | Laboratory Corporation of America | LH | New Coverage | Hold (N/A) |
206.58 (328.95) |
59.24% | Details | |
| 9/6/2023 | Zoetis Inc. | ZTS | New Coverage | Buy (N/A) |
192.52 (81.03) |
-57.91% | Details | |
| 9/6/2023 | UnitedHealth Group | UNH | New Coverage | Hold (N/A) |
476.24 (418.09) |
-12.21% | Details | |
| 9/6/2023 | Livanova | LIVN | New Coverage | Hold (N/A) |
55.85 (80.90) |
44.85% | Details | |
| 9/6/2023 | Johnson & Johnson | JNJ | New Coverage | Hold (N/A) |
160.48 (263.81) |
64.39% | Details | |
| 9/6/2023 | IQVIA Holdings | IQV | New Coverage | Buy (N/A) |
224.33 (279.36) |
24.53% | Details | |
| 9/6/2023 | Gilead Sciences | GILD | New Coverage | Reduce (N/A) |
76.65 (156.04) |
103.57% | Details | |
| 9/6/2023 | bluebird bio | BLUE | New Coverage | Buy (N/A) |
3.90 (4.97) |
27.44% | Details | |
| 9/6/2023 | Biogen | BIIB | New Coverage | Buy (N/A) |
267.17 (250.69) |
-6.17% | Details | |
| 9/6/2023 | Amgen | AMGN | New Coverage | Buy (N/A) |
256.71 (393.17) |
53.16% | Details | |
| 9/6/2023 | Actinium Pharma | ATNM | New Coverage | Buy (N/A) |
6.65 (1.52) |
-77.14% | Details |
